ArticleFrontiers in oncology2021

Potential Clinical Value of Pretreatment De Ritis Ratio as a Prognostic Biomarker for Renal Cell Carcinoma.

Jinze Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.